SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
274 hedge funds and large institutions have $6.93B invested in Sage Therapeutics in 2018 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 95 increasing their positions, 90 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.6% more ownership
Funds ownership: 104.44% → 105.04% (+0.6%)
9% less capital invested
Capital invested by funds: $7.6B → $6.93B (-$673M)
50% less funds holding in top 10
Funds holding in top 10: 14 → 7 (-7)
Holders
274
Holding in Top 10
7
Calls
$63.1M
Puts
$62.1M
Top Buyers
| 1 | +$53.5M | |
| 2 | +$37.1M | |
| 3 | +$33.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$21.7M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$17.5M |
Top Sellers
| 1 | -$33.9M | |
| 2 | -$28.1M | |
| 3 | -$23.2M | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$16.4M |
| 5 |
D.E. Shaw & Co
New York
|
-$13.7M |